Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Other(3)

Detailed Status

unknown3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown375%
completed125%

Recent Activity

0 active trials
Showing 4 of 4
unknownnot_applicable

Cardiac Shock Wave Therapy for the Treatment of Myocardial Infarction With Non-obstructive Coronary Arteries

NCT05935436
unknown

Implication of Cardiac Shock Wave Therapy on Coronary Artery Disease Patients

NCT04694157
completednot_applicable

Implication of Cardiac Shock Wave Therapy on Coronary Artery Disease

NCT03053128
unknownnot_applicable

Improvement of Cardiac Function in Patients With Ischemic Cardiomyopathy by Extracorporeal Shock Wave Therapy: a Multicenter Clinical Study

NCT03398096

Clinical Trials (4)

Showing 4 of 4 trials
NCT05935436Not Applicable

Cardiac Shock Wave Therapy for the Treatment of Myocardial Infarction With Non-obstructive Coronary Arteries

Unknown
NCT04694157

Implication of Cardiac Shock Wave Therapy on Coronary Artery Disease Patients

Unknown
NCT03053128Not Applicable

Implication of Cardiac Shock Wave Therapy on Coronary Artery Disease

Completed
NCT03398096Not Applicable

Improvement of Cardiac Function in Patients With Ischemic Cardiomyopathy by Extracorporeal Shock Wave Therapy: a Multicenter Clinical Study

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4